• Welcome to Miami: New Products and Launches at SCOPE 2017

    Clinical Informatics News | Several companies took advantage of the 8th annual Summit for Clinical Ops Executives to make new product and business announcements. Here are a few of the exciting things heard and seen on the show floor.

    Jan 27, 2017

  • Illumina, Medidata, Rho, And More: News From January 2017

    Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from Illumina, Medidata, Rho, and more. 

    Jan 26, 2017

  • 2017 Clinical Informatics News Best Practices Awards Winners Announced

    Clinical Informatics News | The winners of the Clinical Informatics News Best Practices Awards were announced on Wednesday at the Summit for Clinical Ops Executives, SCOPE, in Miami, Fla. Prizes were awarded to Mytrus, CluePoints, and DrugDev.

    Jan 25, 2017

  • Merck & Co. Opens Cambridge Exploratory Science Center, Plans To Hire 30 More Employees

    BioSpace.com |  The end of 2016 brought a new beginning with Merck's opening of its new Exploratory Science Center (ESC) in Cambridge, a cutting edge facility that will focus on early discovery research.

    Jan 24, 2017

  • FDA Launches Oncology Center For Excellence

    Clinical Informatics News Briefs | Even as rumors and speculation swirl around the new head of FDA under President Trump, the U.S. Food and Drug Administration announced today that it is establishing the Oncology Center of Excellence and appointing Dr. Richard Pazdur as its director.

    Jan 19, 2017

  • New FDA Chief Should Have Medical Experience Drugmakers Say

    Bloomberg.com |  President-elect Donald Trump's pick to lead the U.S. Food and Drug Administration should have a medical background, and the agency should continue evaluating new medications' effectiveness, drugmaker executives said in comments indicating opposition to two candidates for the regulator's top post.

    Jan 18, 2017

  • New Rule On Clinical Trial Reporting Doesn't Go Far Enough

    STAT |  A new rule requiring that all NIH-sponsored clinical trials be reported on ClinicalTrials.gov doesn't go far enough to improve sharing trial information.

    Jan 17, 2017

  • Site-Less Clinical Trial Depends On Pharmacists' Relationships With Patients

    Clinical Informatics News | Center Point Clinical Services, a contract research organization, launched what it calls “the world's first site-less, technology CRO,” designed to increase patient recruitment, engagement, and successful trial completions at lower cost.

    Jan 17, 2017

  • Using Real World Data to Enhance Clinical Trials

    Clinical Informatics News Contributed Commentary | Randomized clinical trials remain the trusted standard for assessing pharmaceutical drug and medical device safety and efficacy. Real world data can provide important health information about patients in the social context of their day-to-day lives.

    Jan 12, 2017

  • Sarah Cannon And Genospace Announce Merger To Enhance Cancer Care

    Clinical Informatics News Brief | Sarah Cannon today announced that Genospace will merge with its organization and become a wholly-owned subsidiary. Sarah Cannon and Genospace will harness and use molecular profiling data to more effectively match cancer patients to therapies in clinical trials.

    Jan 12, 2017

  • 2017 Best Practices Finalists Announced

    Clinical Informatics News Brief | Clinical Informatics News today announced nine finalists in its 2017 Best Practices Awards. Three of the finalists will be named winners at SCOPE, the Summit for Clinical Ops Executives in Miami, Florida, on January 25.

    Jan 11, 2017

  • Diversity In Clinical Trials: An Issue That We Can No Longer Ignore

    MedCity News |   Minorities-along with the elderly and women-have historically been underrepresented in clinical trials. FDA Commissioner Robert Califf called 2016 "The Year of Diversity in Clinical Trials." So how have we done?

    Jan 6, 2017

  • Biden To Tackle Broad Range of Cancer Issues Including Drug Prices After Leaving White House

    The Washington Post |  In an interview, Biden outlines his post-White House plans for accelerating progress against cancer. He plans a nonprofit organization to focus on many of the "moonshot" issues including data sharing and clinical trials.

    Jan 5, 2017